Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
Open Access
- 15 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 205 (suppl_2), S147-S158
- https://doi.org/10.1093/infdis/jir860
Abstract
Tuberculosis is unique among the major infectious diseases in that it lacks accurate rapid point-of-care diagnostic tests. Failure to control the spread of tuberculosis is largely due to our inability to detect and treat all infectious cases of pulmonary tuberculosis in a timely fashion, allowing continued Mycobacterium tuberculosis transmission within communities. Currently recommended gold-standard diagnostic tests for tuberculosis are laboratory based, and multiple investigations may be necessary over a period of weeks or months before a diagnosis is made. Several new diagnostic tests have recently become available for detecting active tuberculosis disease, screening for latent M. tuberculosis infection, and identifying drug-resistant strains of M. tuberculosis. However, progress toward a robust point-of-care test has been limited, and novel biomarker discovery remains challenging. In the absence of effective prevention strategies, high rates of early case detection and subsequent cure are required for global tuberculosis control. Early case detection is dependent on test accuracy, accessibility, cost, and complexity, but also depends on the political will and funder investment to deliver optimal, sustainable care to those worst affected by the tuberculosis and human immunodeficiency virus epidemics. This review highlights unanswered questions, challenges, recent advances, unresolved operational and technical issues, needs, and opportunities related to tuberculosis diagnostics.Keywords
This publication has 71 references indexed in Scilit:
- Evaluation of Tuberculosis Diagnostics in Children: 2. Methodological Issues for Conducting and Reporting Research Evaluations of Tuberculosis Diagnostics for Intrathoracic Tuberculosis in Children. Consensus From an Expert PanelaThe Journal of Infectious Diseases, 2012
- Drug-Resistant Tuberculosis—Current Dilemmas, Unanswered Questions, Challenges, and Priority NeedsThe Journal of Infectious Diseases, 2012
- TuberculosisThe Lancet, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospectsPaediatric Respiratory Reviews, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Dynamic antibody responses to the Mycobacterium tuberculosis proteomeProceedings of the National Academy of Sciences of the United States of America, 2010
- Rate and Amplification of Drug Resistance among Previously‐Treated Patients with Tuberculosis in Kampala, UgandaClinical Infectious Diseases, 2008
- Reducing the global burden of tuberculosis: the contribution of improved diagnosticsNature, 2006
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBThe New England Journal of Medicine, 2006